1. Home
  2. WALD vs CABA Comparison

WALD vs CABA Comparison

Compare WALD & CABA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WALD
  • CABA
  • Stock Information
  • Founded
  • WALD 1988
  • CABA 2017
  • Country
  • WALD United States
  • CABA United States
  • Employees
  • WALD N/A
  • CABA N/A
  • Industry
  • WALD Package Goods/Cosmetics
  • CABA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • WALD Consumer Discretionary
  • CABA Health Care
  • Exchange
  • WALD Nasdaq
  • CABA Nasdaq
  • Market Cap
  • WALD 228.8M
  • CABA 200.3M
  • IPO Year
  • WALD 2021
  • CABA 2019
  • Fundamental
  • Price
  • WALD $1.89
  • CABA $2.85
  • Analyst Decision
  • WALD Strong Buy
  • CABA Strong Buy
  • Analyst Count
  • WALD 5
  • CABA 8
  • Target Price
  • WALD $4.96
  • CABA $11.63
  • AVG Volume (30 Days)
  • WALD 89.5K
  • CABA 5.1M
  • Earning Date
  • WALD 11-11-2025
  • CABA 11-13-2025
  • Dividend Yield
  • WALD N/A
  • CABA N/A
  • EPS Growth
  • WALD N/A
  • CABA N/A
  • EPS
  • WALD N/A
  • CABA N/A
  • Revenue
  • WALD $273,868,000.00
  • CABA N/A
  • Revenue This Year
  • WALD $10.37
  • CABA N/A
  • Revenue Next Year
  • WALD $14.37
  • CABA N/A
  • P/E Ratio
  • WALD N/A
  • CABA N/A
  • Revenue Growth
  • WALD 25.55
  • CABA N/A
  • 52 Week Low
  • WALD $1.48
  • CABA $0.99
  • 52 Week High
  • WALD $4.18
  • CABA $5.46
  • Technical
  • Relative Strength Index (RSI)
  • WALD 49.65
  • CABA 60.41
  • Support Level
  • WALD $1.80
  • CABA $2.23
  • Resistance Level
  • WALD $2.07
  • CABA $3.08
  • Average True Range (ATR)
  • WALD 0.13
  • CABA 0.34
  • MACD
  • WALD -0.01
  • CABA 0.02
  • Stochastic Oscillator
  • WALD 33.33
  • CABA 50.45

About WALD Waldencast plc

Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.

About CABA Cabaletta Bio Inc.

Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells, that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies: CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) that have the potential to be applied across a broad range of autoimmune diseases.

Share on Social Networks: